Boceprevir/Peginterferon/Ribavirin for Chronic Hepatitis C: Erythropoietin Use Versus Ribavirin Dose Reduction for Anemia (P06086 AM2)

NCT01023035 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

687

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: Boceprevir
DRUG: Peginterferon alfa-2b (PEG2b)
DRUG: Ribavirin (RBV)
DRUG: Erythropoietin

Sponsor

Merck Sharp & Dohme LLC